We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
Dr. Robert Ryan is currently the CEO of Innova Therapeutics, which is a biotech based in South Carolina focused on the development of several pharmaceutical programs in the Orphan disease space. Dr. Ryan was previously CEO and co-founder of Scioderm, which is a company that developed a topical therapy for Epidermolysis Bullosa. Scioderm was the first Biotech to receive “Breakthrough Therapy” designation from the FDA and was also recognized by Fierce Biotech as one of the Fierce 15, considered as one of the most promising Biotechs in the world. In addition, Dr. Ryan led the successful sale of Scioderm to Amicus in September 2015 for approximately $957M, in a period of less than 2.5 years from initiation of the company and a total spend of less than $25M.
Dr. Ryan has more than 27 years of research/pharmaceutical/biotech experience, spanning the global development process from preclinical through Phase IV. Dr. Ryan previously held senior regulatory positions at three of the top five lead
This speaker's sessions: